These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24251545)

  • 21. Importance of V3 loop flexibility and net charge in the context of co-receptor recognition. A molecular dynamics study on HIV gp120.
    Chandramouli B; Chillemi G; Abbate I; Capobianchi MR; Rozera G; Desideri A
    J Biomol Struct Dyn; 2012; 29(5):879-91. PubMed ID: 22292949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Silico Identification of Novel Aromatic Compounds as Potential HIV-1 Entry Inhibitors Mimicking Cellular Receptor CD4.
    Andrianov AM; Nikolaev GI; Kornoushenko YV; Xu W; Jiang S; Tuzikov AV
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31412617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual specificity of a monoclonal anti-idiotypic antibody for HIV-1 neutralizing monoclonals 110.3 and 110.4 as well as the V3 loop of gp120.
    Connelly RJ; Kahn M; Blake J; Haffar OK; Thomas EK
    Virology; 1994 Dec; 205(2):554-7. PubMed ID: 7526543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.
    Vu HM; de Lorimier R; Moody MA; Haynes BF; Spicer LD
    Biochemistry; 1996 Apr; 35(16):5158-65. PubMed ID: 8611499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid-state NMR evidence for an antibody-dependent conformation of the V3 loop of HIV-1 gp120.
    Weliky DP; Bennett AE; Zvi A; Anglister J; Steinbach PJ; Tycko R
    Nat Struct Biol; 1999 Feb; 6(2):141-5. PubMed ID: 10048925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SAXS data analysis and modeling of tetravalent neutralizing antibody CD4-IgG2 -/+ HIV-1 gp120 revealed that first two gp120 bind to the same Fab arm.
    Rathore YS; Solanki AK; Dhoke RR; Ashish
    Biochem Biophys Res Commun; 2011 Dec; 415(4):680-5. PubMed ID: 22079291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.
    Stanfield RL; Gorny MK; Williams C; Zolla-Pazner S; Wilson IA
    Structure; 2004 Feb; 12(2):193-204. PubMed ID: 14962380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure determination of an anti-HIV-1 Fab 447-52D-peptide complex from an epitaxially twinned data set.
    Dhillon AK; Stanfield RL; Gorny MK; Williams C; Zolla-Pazner S; Wilson IA
    Acta Crystallogr D Biol Crystallogr; 2008 Jul; D64(Pt 7):792-802. PubMed ID: 18566514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression, purification, and isotope labeling of a gp120 V3 peptide and production of a Fab from a HIV-1 neutralizing antibody for NMR studies.
    Sharon M; Görlach M; Levy R; Hayek Y; Anglister J
    Protein Expr Purif; 2002 Apr; 24(3):374-83. PubMed ID: 11922753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local structural properties of the V3 loop of Thailand HIV-1 isolate.
    Andrianov AM
    J Biomol Struct Dyn; 2002 Jun; 19(6):973-89. PubMed ID: 12023800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and evaluation of HIV-1 entry inhibitors based on broadly neutralizing antibody 447-52D and gp120 V3loop interactions.
    Senapathi J; Bommakanti A; Vangara S; Kondapi AK
    Bioorg Chem; 2021 Nov; 116():105313. PubMed ID: 34517280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational preferences of the HIV-1 principal neutralizing determinant.
    Andrianov AM
    J Biomol Struct Dyn; 2005 Dec; 23(3):267-82. PubMed ID: 16218754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus-1 gp120 V3 loop for anti-acquired immune deficiency syndrome drug discovery: computer-aided approaches to the problem solving.
    Andrianov AM
    Expert Opin Drug Discov; 2011 Apr; 6(4):419-35. PubMed ID: 22646019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 V3 loop crown epitope-focused mimotope selection by patient serum from random phage display libraries: implications for the epitope structural features.
    Gazarian KG; Palacios-Rodríguez Y; Gazarian TG; Huerta L
    Mol Immunol; 2013 Jun; 54(2):148-56. PubMed ID: 23270686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study of conformational homology for the HIV-1 gpi20 V3 loop. structural analysis of the HIV-RF and HIV-Thailand viral strains].
    Andrianov AM
    Biomed Khim; 2006; 52(5):448-57. PubMed ID: 17180919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antigenic structure of the HIV gp120 envelope glycoprotein.
    Wyatt R; Kwong PD; Desjardins E; Sweet RW; Robinson J; Hendrickson WA; Sodroski JG
    Nature; 1998 Jun; 393(6686):705-11. PubMed ID: 9641684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structure of a human rhinovirus that displays part of the HIV-1 V3 loop and induces neutralizing antibodies against HIV-1.
    Ding J; Smith AD; Geisler SC; Ma X; Arnold GF; Arnold E
    Structure; 2002 Jul; 10(7):999-1011. PubMed ID: 12121655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Computer modeling of the promising inhibitors of the HIV-1 subtype A replication as a framework for the rational anti-aids drug design].
    Andrianov AM; Anishchenko IV
    Biomed Khim; 2011; 57(2):161-73. PubMed ID: 21870601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.